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Mitomycin C-Induced Reduction of Keratocytes and
Fibroblasts after Photorefractive Keratectomy
Tae-im Kim, Jhang Ho Pak, Sun Young Lee, and Hungwon Tchah
PURPOSE. To investigate the effects of mitomycin C (MMC) on
the number of keratocytes and the proliferation of fibroblasts
after photorefractive keratectomy (PRK) and exposure to ul-
traviolet B (UV-B) irradiation.
METHODS. The right eyes of New Zealand White rabbits in
Groups 1, 2, and 3 (n  18 each) underwent PRK to correct
10 diopters with 5 mm optical zone. Sponges soaked with
0.02% MMC were applied to the right eyes of Group 1 rabbits
for 2 minutes. Antibiotic ointment was applied daily to all
rabbits until the epithelium healed completely, after which
0.02% MMC eye drops were applied twice daily to the right
eyes in Group 2 until 4 weeks after PRK. Three weeks after
PRK, the right eyes of all the remaining rabbits were exposed
to 100 mJ/cm2 C UV-B radiation. Corneal haziness was assessed
biomicroscopically using the Fantes scale every 3 weeks. Six
eyes of each group were each enucleated 3, 6, and 12 weeks
after PRK, and tissue specimens were stained with hematoxy-
lin and eosin and with TUNEL stain. The tissues were evaluated
immunohistochemically with antibody to -smooth muscle ac-
tin (SMA). Cellular changes in the anterior stroma and epithe-
lial basement membrane were evaluated by electron micros-
copy.
RESULTS. Corneal haze was observed after PRK and was aggra-
vated by UV-B irradiation. A single intraoperative application of
MMC immediately after PRK induced opacity and apoptosis of
keratocytes. Twelve weeks after PRK, MMC significantly re-
duced corneal haze, the number of keratocytes, apoptotic
cells, and fibroblasts, even after UV-B irradiation. Relatively
large numbers of apoptotic and SMA-positive cells were found
only in PRK-treated, non-MMC treated rabbits (Group 3), even
after 12 weeks. Three weeks after PRK, dying stromal cells
showed cell shrinkage, and chromatin condensation was ob-
served in all treated groups by electron microscopy. Twelve
weeks after PRK, fewer keratocytes and inflammatory cells
were observed just beneath the epithelial layer in Group 1 than
in any of the other groups.
CONCLUSIONS. MMC is a potent inhibitor of corneal haze in-
duced by PRK. MMC reduced the number of keratocytes and
fibroblasts after PRK and UV-B irradiation. Although MMC
would improve the clinical results of PRK, it has significant
toxicity on corneal keratocytes, which did not disappear until
3 months after PRK. (Invest Ophthalmol Vis Sci. 2004;45:
2978–2984) DOI:10.1167/iovs.04-0070
The early disappearance of keratocytes after epithelial injuryis mediated by apoptosis.1–3 The remaining keratocytes
begin to proliferate, which may lead to the generation of
myofibroblasts.4,5 Inflammatory cells have also been observed
to enter the stroma. This complex cellular response contrib-
utes to stromal remodeling and modulates healing of the over-
lying epithelial cells.4 The advent of refractive surgery has
greatly stimulated interest in understanding this apoptotic re-
sponse and the subsequent repopulation of the area of cell
death. Similarly, keratocyte activation after surgery and trauma
has become an area of interest, since corneal wound healing
shows individual variability after photorefractive keratectomy
(PRK) or LASIK.6–9 Modulation of this process at the cellular
and molecular level is thought to be critical for ideal refractive
surgery, with early keratocyte apoptosis regarded as a promis-
ing target for controlling later events in the wound healing
cascade. To date, pharmacological efforts to control early ker-
atocyte apoptosis have not been successful, but research is
ongoing to identify agents that can regulate this phenomenon
and its sequelae.
Mitomycin C (MMC), which suppresses the proliferation of
rapidly growing cells by inhibiting DNA synthesis secondary to
alkylation,10 is used in glaucoma filtering surgery11 and to
prevent recurrence of pterygium.12 In addition, MMC has been
suggested for treating conjunctival and corneal intraepithelial
neoplasia.13,14 In experimental models, MMC acts as a poten-
tial modulator of wound healing after PRK.15–18 Although top-
ical application of MMC prevents haze and recurrence of sub-
epithelial fibrosis after refractive corneal surgery,19–22 adverse
effects of this agent have also been reported,16,18,23 making its
safety of critical importance.
Exposure of the eye to UV radiation results in the develop-
ment of photokeratitis after a few hours.24 The degree of
damage depends on several factors, including the wavelength
of incident light and the length of time of exposure. UV-
induced keratopathy results in reactive production of hyaluro-
nan in keratocytes.28 Similarly, hyaluronan formation has been
found to occur after excimer laser surgery.26 UV-B exposure
during post-PRK stromal healing exacerbates the damage and
prolongs the healing response, as manifested by subepithelial
haze augmentation.27,28 UV-B exposure also modulates tissue
response to excimer laser treatment.
In this study, the modulating effect of MMC on the wound
healing process after PRK, as well as the safety of this agent,
were evaluated. The effect of MMC on keratocyte and myofi-
broblast proliferation in the special environment resulting from
UV-B irradiation after PRK was also studied.
MATERIALS AND METHODS
Surgical Technique and Clinical Protocol
Animals used in this study were treated in accordance with the ARVO
Resolution on the Use of Animals in Research. Seventy-two New
Zealand White rabbits, weighing between 2 and 2.5 kg, were divided
into four groups. Rabbits in Groups 1 to 3 (n  18 each) were
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anesthetized with intramuscular injections of a mixture of ketamine
(25 mg/kg) and xylazine (2 mg/kg). Proparacaine hydrochloride eye
drops were instilled into each right eye, and a speculum was used to
open the eyelids. PRK (5 mm optical zone, 10 diopters) was per-
formed on the right eye of each rabbit with a flying spot excimer laser
(Technolas 217z; Bausch & Lomb Surgical, Munchen, Germany). The
left eyes of Groups 1–3 and both eyes of Group 4 were not treated.
Immediately after PRK, a sponge soaked with 0.02% MMC was
placed for 2 minutes on each exposed corneal bed of the right eyes in
Group 1, and each eye was subsequently irrigated vigorously with a 30
mL-balanced salt solution. An antibiotic (0.3% ofloxacin) ointment was
applied for 3 days onto each right eye in Groups 1 to 3. After complete
epithelial healing and until 4 weeks after PRK, 0.02% MMC eye drops
were applied twice daily to the right eyes of the rabbits in Group 2.
Three weeks after PRK, 12 rabbits in each of the four groups were
anesthetized as above and placed in a standard dermatologic UV light
chamber. The right eyes were kept open using a speculum and ex-
posed for 1 to 2 minutes to UV light at a wavelength in the UV-B range
(290 to 315 nm) and with total equivalent energy of 100 mJ/cm2.
Stromal haziness was assessed biomicroscopically29 every 3 weeks
thereafter.
Tissue Processing and Sections
Six rabbits in each group were killed at weeks 3, 6, and 12, by
intravenous injection of 10 mL air, and their eyes were enucleated. The
corneas were fixed in 4% paraformaldehyde, embedded in paraffin
wax, and sectioned into 5 m slices. Sections were double-stained
with hematoxylin and eosin.
TUNEL Stain and Immunohistochemical Assay
The number of apoptotic cells in each cornea was determined using
the In Situ Cell Death Detection Kit (Roche Diagnostics Korea Co.,
Seoul, Korea) and the fluorescein simplified TUNEL assay. Fluorescein
quantitates cell death (apoptosis) by labeling DNA strand breaks in
individual cells, allowing their detection by fluorescence microscopy.
The assay uses an optimized terminal transferase (TdT) to label free
3OH ends in genomic DNA with fluorescein-dUTP. Photographs were
obtained with a fluorescence microscope (LEITZ DM LB2; Leica,
Wetzlar, Germany).
For immunohistochemical assays, the sections were incubated for 1
hour at room temperature with a monoclonal anti-SMA antibody
(DAKO, Glostrup, Denmark), a myofibroblast marker, and assayed
using a Ventana: i View DAB detection kit (Ventana, Tucson, AZ). All
sections were counterstained with hematoxylin to detect nuclei. The
sections were viewed and photographed with a microscope equipped
with a digital camera (Coolpix 950; Nikon, Tokyo, Japan).
Transmission Electron Microscopy
Central corneal sections obtained with a flat cutter were fixed over-
night at 4°C in 2.5% glutaraldehyde and washed twice with PBS for 5
minutes each. Each cornea was bisected, and a 1-mm strip was ob-
tained from its center, fixed in 1% OsO4 in phosphate buffer for
approximately 90 minutes at room temperature, washed twice in
phosphate-buffered fixative vehicle, and dehydrated using a graded
ethanol series. The transition from 100% ethanol to epoxy was medi-
ated by two changes of propylene oxide, and a pure epoxy medium
was used for infiltration and embedding. The fragments were mounted
in flat molds and hardened at 80°C overnight before sectioning. Both
600–1000 nm and 60–80 nm TEM sections were cut onto polyvinyl
butyral-coated grids (Pioloform; Sigma, St Louis, MO) and stained with
saturated aqueous uranyl acetate and lead citrate. Evaluation was per-
formed by TEM (JEM1200 EX2; Jeol LTD, Tokyo, Japan).
Cell Counting and Statistical Analysis
Six specimens from each group were used for counting at each time
point, with the cells in five non-overlapping, stromal fields counted by
one observer (TK) in a X400 power field. To reduce possible investi-
gator bias, this procedure was performed in a blinded fashion on
serially numbered slides. Data were analyzed using SPSS software (SPSS
Inc., Chicago, IL). Statistical comparisons between the groups were
performed using ANOVA test with Bonferonni correction.
RESULTS
Clinical Course
Subepithelial haze was observed in the ablation area of all
treated rabbits 3 weeks after PRK. During the early postoper-
ative period, rabbits in Groups 1, 2, and 3 displayed a similar
degree of corneal haze (Fig. 1). Six weeks after PRK, corneal
haze increased in all rabbits in Groups 2 and 3. Twelve weeks
after PRK, Group 1 rabbits exhibited a lesser degree of haze
than did the other groups (P  0.01). Although the Group 2
FIGURE 1. Quantitation of corneal haze after PRK, in Group 1 (f),
Group 2 (o), Group 3 (u), and Group 4 (). Error bars: SD of the
mean; *statistically different from Group 4 (P  0.01).
FIGURE 2. Quantitation of number of keratocytes after PRK, in Group
1 (f), Group 2 (o), Group 3 (u), and Group 4 (). Error bars: SD of
the mean; *statistically different from Group 4 (P  0.01) (103/
m2  SD).
FIGURE 3. Quantitation of TUNEL-positive cells in the stroma after
PRK, in Group 1 (f), Group 2 (o), Group 3 (u), and Group 4 ().
Error bars: SD of the mean; *statistically different from Group 4 (P 
0.01).
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FIGURE 4. Immunolocalization of SMA at 3 weeks (A, B, C) and 12 weeks (D, E, F) after PRK. SMA appears as brown or black and the hematoxylin
counterstain is blue. Three weeks after PRK, all treated groups showed some anti-SMA binding in subepithelial and anterior stroma in the corneal
wound area. However, 12 weeks (D, E, F) after PRK, SMA-positive cells were observed in anterior and posterior stroma. Group 1 (D) showed some
SMA-positive stromal cells at anterior stroma and Group 2 (E) showed SMA-positive stromal cells at anterior and posterior stroma. Especially in
Group 3 (F), the number of positive cells continued to be significantly greater than other groups at 3 months after surgery. Magnification, 200.
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rabbits showed slightly lower grade haze than the Group 3
rabbits, this difference was not statistically significant. After UV
irradiation, rabbits in Group 4 also showed mild haze forma-
tion.
Histologic Findings
Three weeks after PRK, light microscopy was unable to detect
any statistically significant between-group differences in the
number of keratocytes, except for differences between Group
4 and the other groups (Fig. 2). In all PRK-treated rabbits,
morphologic changes were evident, including epithelial irreg-
ularity, stromal edema, irregular scar tissue, and the presence
of collagen.
Six weeks after PRK, the number of keratocytes was slightly
decreased in Groups 1 and 2 and slightly increased in Groups
3 and 4. Twelve weeks after PRK, the number of keratocytes
decreased in Groups 1, 2, and 3. Compared with the rabbits in
Group 3, the rabbits in Groups 1 and 2 had significantly lower
numbers of keratocytes, with the most significant decrease
observed in Group 1.
Evaluation of Apoptosis
Chromatin condensation is a marker of apoptosis, which can
be detected using TUNEL stain. Three weeks after PRK, apo-
ptotic keratocytes were detected in the corneas of all PRK-
treated rabbits, mostly in the anterior portion of the corneas.
Compared with Group 3, the rabbits in Groups 1 and 2 had
relatively severe apoptotic processes (Fig. 3).
Six weeks after PRK, apoptotic keratocytes were observed
in the entire stromal layer, but Group 1 had a significantly
lower number of these cells (P  0.01). Twelve weeks after
PRK, the number of apoptotic cells had decreased in all
groups, most significantly in Group 1 (P  0.01).
Immunohistochemical Assay
Three weeks after PRK, Group 3 eyes had a greater number of
SMA-positive cells than the other groups (P  0.001; Fig. 4),
but no SMA-stained cells were observed in unwounded stroma.
All PRK-treated rabbit eyes had small numbers of anti-SMA
binding cells in the subepithelial and anterior stroma of the
corneal wound area (Fig. 5). Twelve weeks after PRK, how-
ever, SMA-positive cells were observed in both the anterior and
posterior stroma, with significant differences among Groups 1,
2, and 3 (P  0.01), but no difference between Groups 1 and
4. Three months after surgery, the number of positive cells was
significantly greater in Group 3 than in any of the other groups.
Transmission Electron Microscopy
The central corneas were examined by electron microscopy 3,
6, and 12 weeks after PRK. At 3 weeks after PRK, dying stromal
cells had shrunk, and chromatin condensation was observed
(Fig. 6), with some of the dead cells having undergone apo-
ptosis. Irregular epithelial basement membrane and infiltration
of many polymorphonuclear leukocytes and monocytes were
observed in the corneas of Groups 1, 2, and 3 rabbits. In
addition, their collagen bundles had become irregular, and
there were deposits of disorganized matrix material and large
amounts of rough endoplasmic reticulum (RER). There were
no significant differences in morphology, however, among
these three groups.
Twelve weeks after PRK, there were very few keratocytes
or inflammatory cells in the Group 1 corneas. Although the
collagen bundles were less irregular, the epithelial basement
membranes did not recover their consistency, having been
replaced by amorphous linear structures. Consistency of the
epithelial basement membrane was observed in Group 2 cor-
neas, with few inflammatory cells and restoration of some
myofibroblasts or keratocytes. Relatively patent epithelial base-
ment membrane was found in Group 3 corneas, but there was
some irregularity, and the collagen fibers were more irregular
than in Group 1. In addition, relatively large amounts of RER
were observed in Group 3 myofibroblasts.
DISCUSSION
Epithelial injury or surgical trauma, such as that associated
with PRK, induces keratocyte apoptosis,7,8 leading the sur-
rounding keratocytes to proliferate and replenish the ante-
rior stroma.6,8 During this process, some activated kerato-
cytes differentiate into fibroblasts or myofibroblasts.6 This
wound healing process may be related to regression and
haze formation after PRK.
MMC, which prevents corneal haze, is the most commonly
used pharmacologic agent for modulating the wound healing
process after PRK.19,20 MMC has been reported to decrease the
number of keratocytes after PRK,16 however, suggesting that
there are long-term safety concerns in the use of this agent.
The present study showed that MMC reduced corneal
haze after PRK and after UV-B irradiation subsequent to PRK.
A single intraoperative application of MMC was more effec-
tive than its topical application in preventing corneal haze.
At 3 weeks after PRK, there was no statistically significant
difference in the number of keratocytes among Groups 1, 2,
and 3. There was significant decrease in cell density in the
Group 1 rabbits at week 12. Moreover, cell density of the
rabbits in Group 1 was lower than that of the control,
untreated rabbits (Group 4) after 3 weeks. These findings
can be compared with those of an earlier report,18 showing
that MMC decreased the number of keratocytes 1 week after
PRK; the number of cells slowly increased thereafter, be-
coming normalized after approximately 12 weeks. This
study differs from the earlier report in that corneas were
irradiated with UV-B 3 weeks after PRK. Moreover, while
treatment with PRK and MMC caused an initial increase in
cell number, the number of keratocytes was significantly
lower than normal and slowly decreased over time, but was
not influenced by UV-B irradiation. Although the clinical
importance of this reduction in cell density is not known, it
may influence long-term corneal survival.
In our previous study,17 MMC induced apoptosis of activated
keratocytes. The results shown here confirm the apoptotic
effects of MMC, as detected by TUNEL staining. While epithe-
lial injury and surgical damage induced apoptotic changes,7–9
MMC was expected to have additional apoptotic effects.17 Six
FIGURE 5. Quantitation of SMA-positive cells in the stroma after PRK,
in group 1 (f), group 2 (o), group 3 (u), and group 4 (). Error bars:
SD of the mean; *statistically different from Group 4 (P  0.01).
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FIGURE 6. Transmission electron microscopy of the central treatment area of rabbit cornea at 3 weeks (A, B, C) and 12 weeks (D, E, F) after PRK.
Dying stromal cells with cell shrinkage, chromatin condensation, irregular epithelial basement membrane, and infiltration of many polymorpho-
nuclear leukocytes and monocytes were observed in Groups 1 (A), 2 (B), and 3 (C) at 3 weeks after PRK. At 12 weeks after PRK, Group 1 (D)
showed very few keratocytes and inflammatory cells and inconsistent epithelial basement membrane. Group 2 (E) showed the linear epithelial
basement membrane and rare inflammatory cells. Group 3 (F) showed a relatively patent epithelial basement membrane and irregular collagen.
Relatively high amounts of rough endoplasmic reticulum (RER) were observed in myofibroblasts. Magnification, 3000
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weeks after PRK, rabbits treated intraoperatively with MMC
had fewer TUNEL-positive cells than did rabbits treated with
MMC drops or those that were not treated with MMC. In
addition, UV-B treatment alone increased the number of
TUNEL-positive cells, which confirms a previous report that
UV light of wavelength 310 nm can induce keratocyte apopto-
sis through the full thickness of the cornea.30
Four hours after PRK for high myopia (9.0 D) in rabbits,
there are large numbers of TUNEL-positive cells, which
become fewer over time and disappear after 4 weeks.9 In
our study, however, TUNEL-positive cells were observed 6
weeks after PRK, which may be due to the induction of
apoptosis in the remaining keratocytes by UV irradiation at
week 3. In addition, significantly fewer TUNEL-positive cells
were observed in rabbits intraoperatively treated with MMC,
perhaps due to the decreased number of remaining kerato-
cytes.
When PRK-, MMC-treated rabbits were compared with con-
trol rabbits after UV-B irradiation, 6 weeks after PRK, the
number of keratocytes was similar, but the number of TUNEL-
positive cells was higher in the former group. While the apo-
ptotic response in the control group was caused by UV irradi-
ation only, the other group had experienced surgical damage
and MMC treatment as well as UV irradiation. These findings
suggest that the different degrees of apoptosis may have been
due to the residual effects of MMC.
After the initial apoptotic response, the remaining kerato-
cytes begin to proliferate. Any myofibroblasts generated5,6 can
be identified by immunohistochemical staining for SMA. Statis-
tically significant differences were observed in SMA-stained
cells between MMC-treated and -untreated rabbits at every time
point. MMC had the most potent effect on rapid proliferating
cells, suppressing the number of SMA-positive cells, which may
explain the clinical differences in outcome, such as corneal
haze.
TEM revealed that the rabbits in Groups 1, 2, and 3 had
similar percentages of apoptotic or necrotic cells and inflam-
matory change. Twelve weeks after PRK, rabbits treated
intraoperatively with MMC did not have re-established epi-
thelial basement membrane, perhaps due to the increased
susceptibility to epithelial damage caused by minimal insults
and delayed healing. The corneas in this group showed scant
cellular components and a relatively regular pattern of col-
lagen fibers. Shown by confocal microscopy, after PRK,
keratocyte density in the anterior stroma is not restored to
the high-density level observed preoperatively.31 In the
present study, MMC induced a more profound reduction of
keratocytes, suggesting that, when combined with PRK,
MMC application may have long-term deleterious effects on
the cornea stroma.
Application of MMC may prevent corneal haze after PRK by
inducing apoptosis of activated keratocytes. A single intraop-
erative application of MMC was more effective than topical
application. Since intraoperative MMC was applied directly
onto the surgical bed, it was easily able to penetrate into the
stroma. In contrast, application of eye drops onto the intact
epithelium did not result in effective penetration of MMC into
the stroma.
In conclusion, MMC induces apoptosis of activated ker-
atocytes and reduces corneal haze after PRK, even when
combined with UV irradiation. Cell loss resulting from the
application of MMC is a serious problem, however, lasting at
least 3 months after PRK. Our results indicate that the
long-term safety of MMC should be considered before its
clinical adoption.
References
1. Wilson SE, He YG, Weng J, et al. Epithelial injury induces kerato-
cyte apoptosis: hypothesized role for the interleukin-1 system in
the modulation of corneal tissue organization and wound healing.
Exp Eye Res. 1996;62:325–327.
2. Wilson SE, Li Q, Weng J, et al. The Fas-Fas ligand system and other
modulators of apoptosis in the cornea. Invest Ophthalmol Vis Sci.
1996;37:1582–1592.
3. Wilson SE, Kim WJ. Keratocyte apoptosis: implications on corneal
wound healing, tissue organization, and disease. Invest Ophthal-
mol Vis Sci. 1998;39:220–226.
4. Wilson SE, Liu JJ, Mohan RR. Stromal-epithelial interactions in the
cornea. Prog Retin Eye Res. 1999;18:293–309.
5. Fini ME. Keratocyte and fibroblast phenotypes in the repairing
cornea. Prog Retin Eye Res. 1999;18:529–551.
6. Jester JV, Petroll WM, Cavanagh HD. Corneal stromal wound heal-
ing in refractive surgery: the role of myofibroblasts. Prog Retin Eye
Res. 1999;18:311–356.
7. Helena MC, Baerveldt F, Kim WJ, Wilson SE. Keratocyte apoptosis
after corneal surgery. Invest Ophthalmol Vis Sci. 1998;39:276–
283.
8. Gao J, Gelber-Schwalb TA, Addeo JV, Stern ME. Apoptosis in the
rabbit cornea after photorefractive keratectomy. Cornea. 1997;16:
200–208.
9. Mohan RR, Hutcheon AE, Choi R, et al. Apoptosis, necrosis, pro-
liferation, and myofibroblast generation in the stroma following
LASIK and PRK. Exp Eye Res. 2003;76:71–87.
10. Calabresi P, Chabner BA. Antineoplastic agents. In: Goodman Gil-
man A, Rall TW, Nies AS, Taylor P, eds. Pharmacological Basis of
Therapeutics. 8th ed. New York: Pergamon Press; 1990:1247–
1248.
11. Bergstrom TJ, Wilkinson WS, Skuta GL, et al. The effects of sub-
conjunctival mitomycin-C on glaucoma filtration surgery in rabbits.
Arch Ophthalmol. 1991;109:1725–1730.
12. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment
for pterygium. Ophthalmology. 1988;95:813–821.
13. Frucht-Pery J, Rozenman Y. Mitomycin C therapy for
corneal intraepithelial neoplasia. Am J Ophthalmol. 1994;117:
164 –168.
14. Wilson MW, Hungerford JL, George SM, et al. Topical mitomycin C
for the treatment of conjunctival and corneal epithelial dysplasia
and neoplasia. Am J Ophthalmol. 1997;124:303–311.
15. Talamo JH, Gollamudi S, Green WR, De La Cruz Z, Filatov V, Stark
WJ. Modulation of corneal wound healing after excimer laser
keratomileusis using topical mitomycin C and steroids. Arch Oph-
thalmol. 1991;109:1141–1146.
16. Schipper I, Suppelt C, Gebbers JO. Mitomycin C reduces scar
formation after excimer laser (193 nm) photorefractive keratec-
tomy in rabbits. Eye. 1997;11:649–655.
17. Kim TI, Tchah H, Lee SA, Sung K, Cho BJ, Kook MS. Apoptosis in
keratocytes caused by mitomycin C. Invest Ophthalmol Vis Sci.
2003;44:1912–1917.
18. Xu H, Liu S, Xia X, Huang P, Wang P, Wu X. Mitomycin C reduces
haze formation in rabbits after excimer laser photorefractive ker-
atectomy. J Refract Surg. 2001;17:342–349.
19. Porges Y, Ben-Haim O, Hirsh A, Levinger S. Phototherapeutic
keratectomy with mitomycin C for corneal haze following pho-
torefractive keratectomy for myopia. J Refract Surg. 2003;19:40–
43.
20. Carones F, Vigo L, Scandola E, Vacchini L. Evaluation of the
prophylactic use of mitomycin-C to inhibit haze formation after
photorefractive keratectomy. J Cataract Refract Surg. 2002;28:
2088–2095.
21. Azar DT, Jain S. Topical MMC for subepithelial fibrosis after refrac-
tive corneal surgery. Ophthalmology. 2001;108:239–240.
22. Majmudar PA, Forstot SL, Dennis RF, et al. Topical mitomycin-C for
subepithelial fibrosis after refractive corneal surgery. Ophthalmol-
ogy. 2000;107:89–94.
23. Yamamoto T, Varani J, Soong HK, Lichter PR. Effects of 5-fluorou-
racil and mitomycin C on cultured rabbit subconjunctival fibro-
blasts. Ophthalmology. 1990;97:1204–1210.
IOVS, September 2004, Vol. 45, No. 9 Mitomycin C Effect on Keratocytes after PRK 2983
24. Pitts DG, Cullen AP, Hacker PD. Ocular effects of ultraviolet radiation
from 295 to 365 nm. Invest Ophthalmol Vis Sci. 1977;16:932–939.
25. Podskochy A, Fagerholm P. Repeated UVR exposures cause ker-
atocyte resistance to apoptosis and hyaluronan accumulation in
the rabbit cornea. Acta Ophthalmol Scand. 2001;79:603–608.
26. Fitzsimmons TD, Fagerholm P, Harfstrand A, et al. Hyaluronic acid
in the rabbit cornea after excimer laser superficial keratectomy.
Invest Ophthalmol Vis Sci. 1992;33:3011–3016.
27. Nagy ZZ, Hiscott P, Seitz B, et al. Ultraviolet-B enhances corneal
stromal response to 193-nm excimer laser treatment. Ophthalmol-
ogy. 1997;104:375–380.
28. Nagy ZZ, Hiscott P, Seitz B, et al. Clinical and morphological
response to UV-B irradiation after excimer laser photorefractive
keratectomy. Surv Ophthalmol. 1997;42 :S64–S76.
29. Fantes FE, Hanna KD, Waring GO 3rd, et al. Wound healing after
excimer laser keratomileusis (photorefractive keratectomy) in
monkeys. Arch Ophthalmol. 1990;108:665–675.
30. Podskochy A, Gan L, Fagerholm P. Apoptosis in UV-exposed rabbit
corneas. Cornea. 2000;19:99–103.
31. Erie JC, Patel SV, McLaren JW, Hodge DO, Bourne WM. Keratocyte
density in the human cornea after photorefractive keratectomy.
Arch Ophthalmol. 2003;1216:770–776.
2984 Kim et al. IOVS, September 2004, Vol. 45, No. 9
